SFM
ELOX

Sphera Funds Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Sphera Funds Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,187
Closed -$2.86M – 136
2018
Q2 		$2.86M Buy
+4,187
New +$2.71M 0.39% 73

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sphera Funds Management's ELOX Position: Q3 2018 in Review

Sphera Funds Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2018, closing a stake of 4,187 shares — an estimated $2.86M sold.

Sphera Funds Management first reported a position in ELOX in Q2 2018 and held it in 1 quarter. The position peaked at $2.86M in Q2 2018. 37 funds tracked by Wall St. Rank hold ELOX as of Q3 2018.

  • Sphera Funds Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Sphera Funds Management sold 4,187 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $2.86M.
  • Sphera Funds Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Sphera Funds Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $2.86M in Q2 2018.
  • 37 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.